Navegar por autor "Vázquez Estévez, Sergio"

A phase II study of cisplatin (CDDP) and oral vinorelbine (NVBO) concomitantly with radiotherapy (RT) in locally advanced (LA) non-small cell lung cancer (NSCLC) treatment: Interim analysis

2012- Firvida Perez, Jose Luis; Vázquez Estévez, Sergio

A phase II study of cisplatin and oral vinorelbine concomitantly with radiotherapy in locally advanced non-small-cell lung cancer treatment: Eficacy and safety results

2013- Firvida Perez, Jose Luis; Vázquez Estévez, Sergio

A phase II study of cisplatin and oral vinorelbine concomitantly with radiotherapy in locally advanced non-small-cell lung cancer treatment: Primary objective and safety results

2013- Firvida Perez, Jose Luis; Vázquez Estévez, Sergio

A Phase II Trial of Erlotinib as Maintenance Treatment After Concurrent Chemo-radiotherapy in Stage III Non-small Cell Lung Cancer (NSCLC) - a Galician Lung Cancer Group (GGCP) Study

2011- Afonso Afonso, Francisco Javier; Firvida Perez, Jose Luis; Vázquez Estévez, Sergio; Barón Duarte, Francisco Javier

A phase II trial of erlotinib as maintenance treatment after concurrent chemoradiotherapy in stage III non-small-cell lung cancer (NSCLC): a Galician Lung Cancer Group (GGCP) study

2013- Afonso Afonso, Francisco Javier; Lazaro Quintela, Martín; Vázquez Estévez, Sergio; Campos Balea, Begoña; Barón Duarte, Francisco Javier; [et al.]

A phase II trial of erlotinib as maintenance treatment after concurrent chemoradiotherapy in stage III non-small-cell lung cancer (NSCLC): a Galician Lung Cancer Group (GGCP) study.

2014- Firvida Perez, Jose Luis; Vázquez Estévez, Sergio; Campos Balea, Begoña; Barón Duarte, Francisco Javier; Alonso-Jaudenes Curbera, Guillermo [et al.]

Analysis of the expression of Wnt signaling ligands in metastatic renal cell carcinomas tissue samples

2012- Antón Aparicio, Luis Miguel; Anido Herranz, Urbano; Fernández Calvo, Ovidio; Firvida Perez, Jose Luis; León Mateos, Luis Ángel; [et al.]

Bevacizumab (B) (10 mg/kg) in combination with cisplatin (C) and docetaxel (D) administered every 2 weeks in patients (p) with advanced non-squamous non-Small Cell Lung Cancer (nsNSCLC): GGCP047/10 study

2013- Firvida Perez, Jose Luis; Lazaro Quintela, Martín; Vázquez Estévez, Sergio; Varela Ferreiro, Silvia; Campos Balea, Begoña; [et al.]

Biweekly docetaxel-cisplatin in chemo-naive patients with advanced squamous carcinoma of the lung: a galician lung cancer group phase ii study

2011- Martín Lázaro, Joaquin; Vázquez Estévez, Sergio

Biweekly docetaxel-cisplatin in chemonaive patients with advanced epidermoid carcinoma of the lung - A phase II study of galician lung cancer group

2011- Afonso Afonso, Francisco Javier; Firvida Perez, Jose Luis; Vázquez Estévez, Sergio; Varela Ferreiro, Silvia

Biweekly docetaxelcisplatin in chemo-naive patients with advanced squamous carcinoma of the lung: A galician lung cancer group phase II study

2011- Lazaro Quintela, Martín; Areses Manrique, María Carmen; Vázquez Estévez, Sergio; Campos Balea, Begoña; Senin Estor, Clara; [et al.]

Carboplatin-Pemetrexed Combination in Elderly Patients with Advanced Non-Squamous Non Small Cell Lung Cancer (NS-NSCLC)

2015- Anido Herranz, Urbano; Fernández Nuñez, Natalia; Areses Manrique, María Carmen; Vázquez Estévez, Sergio; Covela Rúa, Marta [et al.]

Chemotherapy management for unfit patients with metastatic castration-resistant prostate cancer

2019- Anido Herranz, Urbano; Fernández Nuñez, Natalia; Afonso-Afonso, J.; Santome-Couto, L.; Medina-Colmenero, A.; [et al.]

Circulating Proteins Associated with Response and Resistance to Neoadjuvant Chemotherapy in HER2-Positive Breast Cancer

2022- Chantada Vázquez, María Pilar; Conde-Amboage, M.; Graña-López, L.; Vázquez Estévez, Sergio; Bravo López, Susana Belén; [et al.]

Comparing diagnosis, management, and outcomes of synchronous versus metacrhonus brain metastases from testicular germ cell tumors (TGCT): Multinstitutional experience from the Spanish Germ Cell Cancer Group (SGCCG)

2013- Vázquez Estévez, Sergio

Comprehensive overview of the efficacy and safety of sorafenib in advanced or metastatic renal cell carcinoma after a first tyrosine kinase inhibitor

2013- Afonso Afonso, Francisco Javier; Antón Aparicio, Luis Miguel; Anido Herranz, Urbano; Fernández Calvo, Ovidio; León Mateos, Luis Ángel; [et al.]

Concurrent chemoradiation (CCHRT) for stage III non-small cell lung cancer (NSCLC): A phase II study from the galician lung cancer group

2013- Firvida Perez, Jose Luis; Areses Manrique, María Carmen; Vázquez Estévez, Sergio; Campos Balea, Begoña; López Vázquez, María Dolores [et al.]

Concurrent chemoradiation (cchrt) with bi-weekly docetaxel and cisplatin and thoracic radiotherapy for stage iii non-small cell lung cancer (nsclc): a phase ii study from the galician lung cancer group

2012- Firvida Perez, Jose Luis; Castro Gómez, José Enrique; Vázquez Estévez, Sergio; Barón Duarte, Francisco Javier; Taboada Valladares, Maria Begoña [et al.]

Cross-sectional observational study assessing the impact in daily clinical practice of the implementation of cooperative group (SOGUG) guidelines about management of targeted therapies in metastatic renal cell carcinoma (mRCC)(proTECT 2 Study)

2013- León Mateos, Luis Ángel; Lazaro Quintela, Martín; Vázquez Estévez, Sergio

Docetaxel (D) and cisplatin (C) induction chemotherapy followed by biweekly D and C with concurrent thoracic radiotherapy for stage iii nonsmall cell lung cancer (NSCLC). A galician lung cancer group study.

2011- Lazaro Quintela, Martín; Vázquez Estévez, Sergio; Varela Ferreiro, Silvia; Campos Balea, Begoña; Casal Rubio, Joaquín [et al.]

Repositorio digital RUNA

Navegar por autor "Vázquez Estévez, Sergio"

A phase II study of cisplatin (CDDP) and oral vinorelbine (NVBO) concomitantly with radiotherapy (RT) in locally advanced (LA) non-small cell lung cancer (NSCLC) treatment: Interim analysis ﻿

A phase II study of cisplatin and oral vinorelbine concomitantly with radiotherapy in locally advanced non-small-cell lung cancer treatment: Eficacy and safety results ﻿

A phase II study of cisplatin and oral vinorelbine concomitantly with radiotherapy in locally advanced non-small-cell lung cancer treatment: Primary objective and safety results ﻿

A Phase II Trial of Erlotinib as Maintenance Treatment After Concurrent Chemo-radiotherapy in Stage III Non-small Cell Lung Cancer (NSCLC) - a Galician Lung Cancer Group (GGCP) Study ﻿

A phase II trial of erlotinib as maintenance treatment after concurrent chemoradiotherapy in stage III non-small-cell lung cancer (NSCLC): a Galician Lung Cancer Group (GGCP) study ﻿

A phase II trial of erlotinib as maintenance treatment after concurrent chemoradiotherapy in stage III non-small-cell lung cancer (NSCLC): a Galician Lung Cancer Group (GGCP) study. ﻿

Analysis of the expression of Wnt signaling ligands in metastatic renal cell carcinomas tissue samples ﻿

Bevacizumab (B) (10 mg/kg) in combination with cisplatin (C) and docetaxel (D) administered every 2 weeks in patients (p) with advanced non-squamous non-Small Cell Lung Cancer (nsNSCLC): GGCP047/10 study ﻿

Biweekly docetaxel-cisplatin in chemo-naive patients with advanced squamous carcinoma of the lung: a galician lung cancer group phase ii study ﻿

Biweekly docetaxel-cisplatin in chemonaive patients with advanced epidermoid carcinoma of the lung - A phase II study of galician lung cancer group ﻿

Biweekly docetaxelcisplatin in chemo-naive patients with advanced squamous carcinoma of the lung: A galician lung cancer group phase II study ﻿

Carboplatin-Pemetrexed Combination in Elderly Patients with Advanced Non-Squamous Non Small Cell Lung Cancer (NS-NSCLC) ﻿

Chemotherapy management for unfit patients with metastatic castration-resistant prostate cancer ﻿

Circulating Proteins Associated with Response and Resistance to Neoadjuvant Chemotherapy in HER2-Positive Breast Cancer ﻿

Comparing diagnosis, management, and outcomes of synchronous versus metacrhonus brain metastases from testicular germ cell tumors (TGCT): Multinstitutional experience from the Spanish Germ Cell Cancer Group (SGCCG) ﻿

Comprehensive overview of the efficacy and safety of sorafenib in advanced or metastatic renal cell carcinoma after a first tyrosine kinase inhibitor ﻿

Concurrent chemoradiation (CCHRT) for stage III non-small cell lung cancer (NSCLC): A phase II study from the galician lung cancer group ﻿

Concurrent chemoradiation (cchrt) with bi-weekly docetaxel and cisplatin and thoracic radiotherapy for stage iii non-small cell lung cancer (nsclc): a phase ii study from the galician lung cancer group ﻿

Cross-sectional observational study assessing the impact in daily clinical practice of the implementation of cooperative group (SOGUG) guidelines about management of targeted therapies in metastatic renal cell carcinoma (mRCC)(proTECT 2 Study) ﻿

Docetaxel (D) and cisplatin (C) induction chemotherapy followed by biweekly D and C with concurrent thoracic radiotherapy for stage iii nonsmall cell lung cancer (NSCLC). A galician lung cancer group study. ﻿

A phase II study of cisplatin (CDDP) and oral vinorelbine (NVBO) concomitantly with radiotherapy (RT) in locally advanced (LA) non-small cell lung cancer (NSCLC) treatment: Interim analysis

A phase II study of cisplatin and oral vinorelbine concomitantly with radiotherapy in locally advanced non-small-cell lung cancer treatment: Eficacy and safety results

A phase II study of cisplatin and oral vinorelbine concomitantly with radiotherapy in locally advanced non-small-cell lung cancer treatment: Primary objective and safety results

A Phase II Trial of Erlotinib as Maintenance Treatment After Concurrent Chemo-radiotherapy in Stage III Non-small Cell Lung Cancer (NSCLC) - a Galician Lung Cancer Group (GGCP) Study

A phase II trial of erlotinib as maintenance treatment after concurrent chemoradiotherapy in stage III non-small-cell lung cancer (NSCLC): a Galician Lung Cancer Group (GGCP) study

A phase II trial of erlotinib as maintenance treatment after concurrent chemoradiotherapy in stage III non-small-cell lung cancer (NSCLC): a Galician Lung Cancer Group (GGCP) study.

Analysis of the expression of Wnt signaling ligands in metastatic renal cell carcinomas tissue samples

Bevacizumab (B) (10 mg/kg) in combination with cisplatin (C) and docetaxel (D) administered every 2 weeks in patients (p) with advanced non-squamous non-Small Cell Lung Cancer (nsNSCLC): GGCP047/10 study

Biweekly docetaxel-cisplatin in chemo-naive patients with advanced squamous carcinoma of the lung: a galician lung cancer group phase ii study

Biweekly docetaxel-cisplatin in chemonaive patients with advanced epidermoid carcinoma of the lung - A phase II study of galician lung cancer group

Biweekly docetaxelcisplatin in chemo-naive patients with advanced squamous carcinoma of the lung: A galician lung cancer group phase II study

Carboplatin-Pemetrexed Combination in Elderly Patients with Advanced Non-Squamous Non Small Cell Lung Cancer (NS-NSCLC)

Chemotherapy management for unfit patients with metastatic castration-resistant prostate cancer

Circulating Proteins Associated with Response and Resistance to Neoadjuvant Chemotherapy in HER2-Positive Breast Cancer

Comparing diagnosis, management, and outcomes of synchronous versus metacrhonus brain metastases from testicular germ cell tumors (TGCT): Multinstitutional experience from the Spanish Germ Cell Cancer Group (SGCCG)

Comprehensive overview of the efficacy and safety of sorafenib in advanced or metastatic renal cell carcinoma after a first tyrosine kinase inhibitor

Concurrent chemoradiation (CCHRT) for stage III non-small cell lung cancer (NSCLC): A phase II study from the galician lung cancer group

Concurrent chemoradiation (cchrt) with bi-weekly docetaxel and cisplatin and thoracic radiotherapy for stage iii non-small cell lung cancer (nsclc): a phase ii study from the galician lung cancer group

Cross-sectional observational study assessing the impact in daily clinical practice of the implementation of cooperative group (SOGUG) guidelines about management of targeted therapies in metastatic renal cell carcinoma (mRCC)(proTECT 2 Study)

Docetaxel (D) and cisplatin (C) induction chemotherapy followed by biweekly D and C with concurrent thoracic radiotherapy for stage iii nonsmall cell lung cancer (NSCLC). A galician lung cancer group study.